1. Home
  2. CCS vs KYMR Comparison

CCS vs KYMR Comparison

Compare CCS & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCS
  • KYMR
  • Stock Information
  • Founded
  • CCS 2000
  • KYMR 2015
  • Country
  • CCS United States
  • KYMR United States
  • Employees
  • CCS N/A
  • KYMR N/A
  • Industry
  • CCS Homebuilding
  • KYMR Medicinal Chemicals and Botanical Products
  • Sector
  • CCS Consumer Discretionary
  • KYMR Health Care
  • Exchange
  • CCS Nasdaq
  • KYMR Nasdaq
  • Market Cap
  • CCS 2.7B
  • KYMR 2.7B
  • IPO Year
  • CCS 2014
  • KYMR 2020
  • Fundamental
  • Price
  • CCS $71.14
  • KYMR $36.81
  • Analyst Decision
  • CCS Buy
  • KYMR Buy
  • Analyst Count
  • CCS 4
  • KYMR 15
  • Target Price
  • CCS $104.00
  • KYMR $55.27
  • AVG Volume (30 Days)
  • CCS 502.1K
  • KYMR 456.1K
  • Earning Date
  • CCS 01-29-2025
  • KYMR 02-27-2025
  • Dividend Yield
  • CCS 1.64%
  • KYMR N/A
  • EPS Growth
  • CCS 29.19
  • KYMR N/A
  • EPS
  • CCS 10.40
  • KYMR N/A
  • Revenue
  • CCS $4,398,288,000.00
  • KYMR $87,563,000.00
  • Revenue This Year
  • CCS $12.41
  • KYMR N/A
  • Revenue Next Year
  • CCS $8.21
  • KYMR $32.89
  • P/E Ratio
  • CCS $6.81
  • KYMR N/A
  • Revenue Growth
  • CCS 19.12
  • KYMR 86.92
  • 52 Week Low
  • CCS $68.49
  • KYMR $29.24
  • 52 Week High
  • CCS $108.42
  • KYMR $53.27
  • Technical
  • Relative Strength Index (RSI)
  • CCS 40.60
  • KYMR 42.51
  • Support Level
  • CCS $71.15
  • KYMR $36.67
  • Resistance Level
  • CCS $75.01
  • KYMR $38.24
  • Average True Range (ATR)
  • CCS 2.18
  • KYMR 1.78
  • MACD
  • CCS -0.19
  • KYMR 0.06
  • Stochastic Oscillator
  • CCS 11.00
  • KYMR 51.81

About CCS Century Communities Inc.

Century Communities Inc is a construction company that focuses on the residential market. It has five homebuilding segments: West, Mountain, Texas, Southeast, and Century Complete. Its sixth reportable segment is financial services operations, which provides mortgage, title, and insurance services to homebuyers. It has acquired land for homebuilding operations with the primary intent to develop and construct single-family detached or attached homes for sale on the acquired land. The company sells homes through its own sales representatives and independent real estate brokers. It also advertises directly to potential homebuyers through the Internet, newspapers, and trade publications. The company generates the majority revenue from the Mountain segment.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.

Share on Social Networks: